US$ 24.22
glycine and tirzepatide Programs Tirzepatide / Glycine — Maximum
Description
In a diabetic neuropathy model in rats, liraglutide improved pain thresholds and reduced sciatic nerve damage

however, it is not currently approved by the TGA for this indication

(Quenby lost 7 pounds in the first month!) Obviously the patients who experience the best results combine their treatment with focussing on a healthy diet and moving their body daily

The doses studied in TRIUMPH-1 were 4 mg, 9 mg, and 12 mg

Currently, it remains in clinical development, and its off-label use carries unknown risks
